Storkus; Walter J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Storkus; Walter J..The latest application filed is for "epha2 t-cell epitope agonists and uses therefore".

Company Profile

2.16.18

Storkus; Walter J. - Glenshaw PA
Storkus; Walter J. - Pittsburgh PA
Storkus; Walter J - Glenshaw PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Epha2 T-cell Epitope Agonists And Uses Therefore App 20210198333 - Storkus; Walter J. ; et al.	2021-07-01
EPHA2 t-cell epitope agonists and uses therefore Grant 10,781,240 - Storkus , et al. Sept	2020-09-22
Peptide Analogs Capable Of Enhancing Stimulation Of A Glioma-specific Ctl Response App 20200246442 - Kind Code	2020-08-06
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response Grant 10,434,155 - Okada , et al. O	2019-10-08
Epha2 T-cell Epitope Agonists And Uses Therefore App 20190023756 - Storkus; Walter J. ; et al.	2019-01-24
EphA2 T-cell epitope agonists and uses therefore Grant 10,131,699 - Storkus , et al. November 20, 2	2018-11-20
Immunogenic tumor associated stromal cell antigen peptides and methods of their use Grant 9,937,250 - Storkus , et al. April 10, 2	2018-04-10
Engineered Dendritic Cells and Uses for the Treatment of Cancer App 20170312315 - BRAUGHLER; Mark ; et al.	2017-11-02
Engineered dendritic cells and uses for the treatment of cancer Grant 9,675,642 - Braughler , et al. June 13, 2	2017-06-13
Peptide Analogs Capable Of Enhancing Stimulation Of A Glioma-specific Ctl Response App 20170151317 - Okada; Hideho ; et al.	2017-06-01
Epha2 T-cell Epitope Agonists And Uses Therefore App 20170002050 - STORKUS; WALTER J. ; et al.	2017-01-05
Immunogenic Tumor Associated Stromal Cell Antigen Peptides And Methods Of Their Use App 20160220651 - Storkus; Walter J. ; et al.	2016-08-04
EphA2 T-cell epitope agonists and uses therefore Grant 9,359,402 - Storkus , et al. June 7, 2	2016-06-07
Immunogenic tumor associated stromal cell antigen peptides and methods of their use Grant 9,345,770 - Storkus , et al. May 24, 2	2016-05-24
Immunogenic Tumor Associated Stromal Cell Antigen Peptides And Methods Of Their Use App 20140314758 - Storkus; Walter J. ; et al.	2014-10-23
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response Grant 8,859,488 - Okada , et al. October 14, 2	2014-10-14
Epha2 T-cell Epitope Agonists And Uses Therefore App 20140134198 - Storkus; Walter J. ; et al.	2014-05-15
EphA2 T cell epitopes and uses therefor Grant 8,574,584 - Storkus , et al. November 5, 2	2013-11-05
Engineered Dendritic Cells and Uses for the Treatment of Cancer App 20130149290 - BRAUGHLER; J. Mark ; et al.	2013-06-13
EphA2 T-Cell Epitopes and Uses Therefor App 20120201840 - Storkus; Walter J. ; et al.	2012-08-09
Engineered Dendritic Cells and Uses for the Treatment of Cancer App 20120114620 - BRAUGHLER; J. Mark ; et al.	2012-05-10
EphA2 T-cell epitopes and uses therefor Grant 8,114,407 - Storkus , et al. February 14, 2	2012-02-14
Peptide Analogs Capable Of Enhancing Stimulation Of A Glioma-specific Ctl Response App 20100008940 - Okada; Hideho ; et al.	2010-01-14
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response Grant 7,612,162 - Okada , et al. November 3, 2	2009-11-03
Engineered Dendritic Cells and Uses for the Treatment of Cancer App 20090123441 - BRAUGHLER; J. MARK ; et al.	2009-05-14
EphA2 T-cell epitopes and uses therefor App 20080226665 - Storkus; Walter J. ; et al.	2008-09-18
EphA2 T-cell epitopes and uses therefor Grant 7,297,337 - Storkus , et al. November 20, 2	2007-11-20
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response App 20070167375 - Okada; Hideho ; et al.	2007-07-19
EphA2 T-cell epitopes and uses therefor App 20060019899 - Storkus; Walter J. ; et al.	2006-01-26
EphA2 T-cell epitope agonists and uses therefor App 20050048550 - Storkus, Walter J. ; et al.	2005-03-03
Methods for isolation and use of T cell epitopes eluted from viable cells in vaccines for treating cancer patients Grant 6,077,519 - Storkus , et al. June 20, 2	2000-06-20
Elution and identification of T cell epitopes from viable cells Grant 5,989,565 - Storkus , et al. November 23, 1	1999-11-23

Company Registrations

NCAGE Code	43HA3	STORKUS WALTER J
CAGE Code	43HA3	STORKUS, WALTER J
DUNS	603212924	STORKUS, WALTER J

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.